Article in Russian
Reference for citation: Safronova Zh.S., Brazevich D.S., Vasilenok V.L. Peculiarities of risk management in production pharmaceutical companies. Scientific journal NRU ITMO. Series «Economics and Environmental Management». 2025. № 1. Р. 81–90. DOI: 10.17586/2310-1172-2025-18-1-81-90.

Abstract. The subject of the study is risk management of pharmaceutical manufacturing companies. The goal is to identify the peculiarities of risk management in pharmaceutical manufacturing companies. The study included a scientific and theoretical analysis of the concept of "risk management", revealed the ambiguity of interpretations and the uniqueness of approaches to this definition. It is substantiated that a flexible risk management strategy allows companies to continuously improve their processes, increase their competitiveness and attractiveness in the market. Based on a systematic approach, the main stages of risk management are formulated and supplemented. The features of the functioning of pharmaceutical manufacturing companies are shown, consisting in strict regulation of activities, subordination to industry standards, involvement in knowledge-intensive processes of development and production of medicinal products, implying various types of risks. It is emphasized that risk management of pharmaceutical manufacturing companies is included in the licensing requirements and is one of the main conditions of activity. In the course of the study, the methodological foundations of risk management of pharmaceutical companies were analyzed and the specifics of risk management were determined. Conclusions are made about the lack of attention of management to risk management, the lack of specialists in this area, fragmented risk management, etc.

Read the full article 

Keywords: risk, risk management, pharmaceutical manufacturing companies, medicines, quality, criteria, industry standards, methods.

References:

1. Renn O. Tri desyatiletiya issledovaniya riska: dostizheniya i novye gorizonty // Voprosy analiza riska. 1999. T. 1. № 1. S. 80–99. 2. Giddens E. Sud'ba, risk i bezopasnost' // Gumanitarnyi portal URL: https://gtmarket.ru/library/articles/3095 (data obrashcheniya: 19.01.2025). 3. Safronova Zh.S., Brazevich D.S. Ob"ektivnye i sub"ektivnye faktory obrazovatel'nykh riskov studencheskoi molodezhi // Alma mater. Vestnik vysshei shkoly. 2021. № 9. S. 23–27. 4. GOST R ISO 31000-2019. Menedzhment riska. Printsipy i rukovodstvo: nats. standart Rossiiskoi Federatsii: utverzhden i vveden v deistvie Prikazom Federal'nogo agentstva po tekhnicheskomu regulirovaniyu i metrologii ot 10 dekabrya 2019 g. N 1379-st: vzamen GOST R ISO 31000-2010: data vvedeniya 2020-03-01 // Kodeks: elektron, fond pravovoi i normativ.-tekhn. inform. URL: https://docs.cntd.ru/document/1200170125 (data obrashcheniya: 20.01.25). 5. Guzhin A.A., Ezhkova V.G. Risk-menedzhment i metody upravleniya riskami // Innovatsii i investitsii. 2017. № 2. S. 185–189 6. Kuz'min E.A. Kontseptual'nye podkhody k upravleniyu riskami slozhnykh organizatsionno-ekonomicheskikh sistem: sistematizatsiya i kriticheskii analiz // Vestnik Yuzhno-Rossiiskogo gosudarstvennogo tekhnicheskogo universiteta (NPI). 2013. № 2. S. 170–183. 7. Serebryakova T.Yu., Gordeeva O.G. Riski organizatsii: ikh uchet, analiz i kontrol': monografiya. –Moskva: INFRA-M, 2020. 233 s. 8. Radnaeva S.E., Matskevich I.V., Ukhakshinova E.M. Farmatsevticheskaya otrasl' v Rossii: analiz i ekonomicheskie aspekty razvitiya // Vestnik Buryatskogo gosudarstvennogo universiteta. Ekonomika i menedzhment. 2020. № 3. S. 31–40. DOI: 10.18101/2304-4446-2020-3-31-40. 9. Safronova Zh.S., Shaidulin M.R. Analiz ekonomicheskogo razvitiya proizvodstvennogo farmatsevticheskogo rynka lekarstvennykh preparatov // Vestnik evraziiskoi nauki. 2024. T. 16. № 2. 10. GOST R 55094-2012 Resursosberezhenie. Obrashchenie s otkhodami. Printsipy klassifikatsii i kharakteristiki opasnykh otkhodov, podlezhashchikh transgranichnomu peremeshcheniyu nats. standart Rossiiskoi Federatsii: utverzhden i vveden v deistvie Prikazom Federal'nogo agentstva po tekhnicheskomu regulirovaniyu i metrologii ot 14 noyabrya 2012 g. N 795-st // Kodeks: elektron, fond pravovoi i normativ.-tekhn. inform. URL: https://https://docs.cntd.ru/document/1200103185 (data obrashcheniya: 20.01.25). 11. Strategiya razvitiya farmatsevticheskoi promyshlennosti Rossiiskoi Federatsii na period do 2030 goda [Elektronnyi resurs]: URL: http://static. government.ru/media/files /HqCzKkoTf7fzVdKSYbhNiZHzWTEAAQ3p.pdf (data obrashcheniya: 02.02.2025). 12. Klunko N.S., Sirotkina N.V. Osnovnye trendy tsifrovoi transformatsii farmatsevticheskoi otrasli // Organizator proizvodstva. 2021. № 2. S. 89–97. 13. Panfilova E.E. Klyuchevye tendentsii razvitiya farmatsevticheskoi otrasli v usloviyakh tsifrovizatsii // Moskovskii ekonomicheskii zhurnal. 2021. №1. S. 305–318. 14. Zakharenko A.V., Smagulova S.M. Poiskovaya optimizatsiya kak instrument povysheniya konkurentosposobnosti farmatsevticheskikh kompanii v sovremennykh usloviyakh // E-Management. 2020. № 2. S. 32–39. 15. Upravlenie riskami dlya kachestva (ICH Q9(R1)). Perevod: Pharm Advisor, versiya perevoda ot 3/21/2023. [Elektronnyi resurs]: URL: https://pharmadvisor.ru/document/tr3660/ (data obrashcheniya: 04.02.2025). 16. Kashirina A.B., Aladysheva Zh.I., Pyatigorskaya N.V., Belyaev V.V., Beregovykh V.V. Analiz otraslevoi praktiki po upravleniyu riskami dlya kachestva lekarstvennykh sredstv na rossiiskikh farmatsevticheskikh predpriyatiyakh // Farmatsiya i farmakologiya. 2020. № 5. S. 362–376. 17. Burova E.D. i dr. Upravlenie riskami dlya obespecheniya kachestva doklinicheskikh issledovanii lekarstvennykh sredstv / E.D. Burova, S.V. Khod'ko, S.V. Gushchina, M.N. Makarova, V.G. Makarov // Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya. 2017. №1. S. 25-31. 18. Feofilova, A.E. i dr. Risk-orientirovannyi podkhod optimizatsii protsessa farmatsevticheskoi razrabotki lekarstvennykh preparatov / A.E. Feofilova, A.V. Foteeva, N.B. Rostova, V.V. Loginova // Mediko-farmatsevticheskii zhurnal «Pul's». 2022. T. 24. № 4. S. 38–43. Doi: http://dx.doi.org/10.26787/nydha-2686-6838-2022-24-4-38-43. 19. Tret'yakova A.E., Orlov A.S. Sovershenstvovanie sistemy upravleniya kachestvom na farmatsevticheskom predpriyatii za schet vnedreniya effektivnogo risk-menedzhmenta // Mediko farmatsevticheskii zhurnal «Pul's». 2022. T. 24. № 6. S. 100–105. doi: 10.26787/nydha-2686-6838-2022-24-6-100 105. 20. Severin A.P. Aktual'nye voprosy farmatsevticheskogo menedzhmenta na sovremennom etape // Globus. 2020. № 9 (55). S. 19–20.